PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
22-Mar-2022 Coulter Partners places new Chief Scientific and Chief People Officers at Totus Medicines, supporting the drug discovery company’s senior leadership expansion Totus Medicines
22-Mar-2022 Douglas GmbH: DOUGLAS CDO Vanessa Stützle to join LUQOM Group as CEO Douglas GmbH
22-Mar-2022 Eckert & Ziegler Extends Supply Agreement with Sirtex Medical to Chinese Market Eckert & Ziegler Strahlen- und Medizintechnik AG
22-Mar-2022 DEFENCE THERAPEUTICS: AN ANTI-CANCER SOLUTIONS PLATFORM COMPANY ADVANCING ITS VERSATILE ACCUM TECHNOLOGY Defence Therapeutics Inc.
22-Mar-2022 Easyfairs opens registration for new Connect in Pharma event Sciad Newswire
22-Mar-2022 Dermapharm Holding SE: Most successful business year in the company's history - Adjusted Group EBITDA at the upper end of the outlook Dermapharm Holding SE
22-Mar-2022 Evolva’s Board of Directors intends to further strengthen its expertise at upcoming AGM and proposes, among others, the following agenda items: Evolva Holding SA
22-Mar-2022 Uni-Bio Science Group Limited:2021 Annual Results UNI-BIO SCIENCE GROUP LIMITED
21-Mar-2022 Ipsen appoints Guy Oliver as General Manager, UK & Ireland Ipsen
21-Mar-2022 Fresenius Medical Care participates in three-way merger to create premier value-based kidney care provider in the U.S. - next important step in execution of growth strategy 2025 Fresenius Medical Care AG & Co. KGaA
21-Mar-2022 Takeda’s EXKIVITY▼(mobocertinib) granted Conditional Marketing Authorisation in Great Britain Takeda
21-Mar-2022 CD Genomics: Ultralow Input RNA-Seq Service Now Available by Its RNA Solutions Platform CD Genomics
21-Mar-2022 Evotec receives € 3 m milestone payment for Bayer starting Phase II clinical development of DNP programme Evotec SE
21-Mar-2022 Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales Relief Therapeutics Holding SA
21-Mar-2022 Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission Relief Therapeutics Holding SA
21-Mar-2022 Moderna Announces New Supply Agreement for 2023 with Switzerland for Additional Seven Million Doses of Moderna's COVID-19 Booster Vaccine Moderna, Inc.
18-Mar-2022 Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board Vita 34 AG
18-Mar-2022 Vita 34 AG: Change in the Chair of the Management Board Vita 34 AG
18-Mar-2022 Coriolis Pharma and U-Medico Announce a Strategic Alliance Coriolis Pharma
18-Mar-2022 Toxys Opens US Office and Production Facility to Accelerate Growth Toxys BV